Zimmer Biomet Holdings Return on Investment 2010-2024 | ZBH
Current and historical return on investment (ROI) values for Zimmer Biomet Holdings (ZBH) over the last 10 years.
| Zimmer Biomet Holdings ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2024-06-30 | $1.24B | $16.71B | 7.16% |
| 2024-03-31 | $1.22B | $17.43B | 6.95% |
| 2023-12-31 | $1.28B | $17.36B | 7.31% |
| 2023-09-30 | $0.90B | $17.65B | 5.14% |
| 2023-06-30 | $0.87B | $17.57B | 5.04% |
| 2023-03-31 | $0.83B | $17.36B | 4.77% |
| 2022-12-31 | $0.70B | $17.18B | 4.03% |
| 2022-09-30 | $0.86B | $17.31B | 4.90% |
| 2022-06-30 | $0.86B | $17.30B | 4.76% |
| 2022-03-31 | $0.80B | $17.31B | 4.32% |
| 2021-12-31 | $0.86B | $18.13B | 4.49% |
| 2021-09-30 | $1.14B | $19.17B | 5.81% |
| 2021-06-30 | $1.20B | $19.39B | 6.06% |
| 2021-03-31 | $0.80B | $19.99B | 4.04% |
| 2020-12-31 | $0.08B | $19.83B | 0.42% |
| 2020-09-30 | $0.01B | $19.72B | 0.04% |
| 2020-06-30 | $-0.05B | $19.40B | -0.24% |
| 2020-03-31 | $0.33B | $19.61B | 1.76% |
| 2019-12-31 | $1.14B | $19.11B | 6.01% |
| 2019-09-30 | $0.01B | $18.43B | 0.05% |
| 2019-06-30 | $-0.01B | $18.38B | -0.07% |
| 2019-03-31 | $0.08B | $19.85B | 0.38% |
| 2018-12-31 | $0.03B | $19.69B | 0.16% |
| 2018-09-30 | $0.78B | $20.82B | 3.71% |
| 2018-06-30 | $0.77B | $21.46B | 3.71% |
| 2018-03-31 | $0.76B | $21.49B | 3.71% |
| 2017-12-31 | $0.80B | $20.65B | 3.97% |
| 2017-09-30 | $1.02B | $19.65B | 5.08% |
| 2017-06-30 | $1.00B | $19.63B | 4.94% |
| 2017-03-31 | $0.92B | $20.47B | 4.53% |
| 2016-12-31 | $0.82B | $20.34B | 4.01% |
| 2016-09-30 | $0.86B | $20.75B | 4.13% |
| 2016-06-30 | $0.78B | $20.08B | 3.70% |
| 2016-03-31 | $0.44B | $20.78B | 2.07% |
| 2015-12-31 | $0.47B | $21.39B | 2.32% |
| 2015-09-30 | $0.48B | $21.68B | 2.83% |
| 2015-06-30 | $0.61B | $21.88B | 4.59% |
| 2015-03-31 | $1.01B | $15.64B | 10.14% |
| 2014-12-31 | $1.04B | $7.98B | 12.96% |
| 2014-09-30 | $1.16B | $7.97B | 14.55% |
| 2014-06-30 | $1.12B | $8.14B | 14.08% |
| 2014-03-31 | $1.07B | $7.92B | 13.68% |
| 2013-12-31 | $1.07B | $7.97B | 13.87% |
| 2013-09-30 | $0.92B | $7.83B | 12.12% |
| 2013-06-30 | $0.96B | $7.58B | 12.71% |
| 2013-03-31 | $1.05B | $7.42B | 14.00% |
| 2012-12-31 | $1.05B | $7.59B | 14.06% |
| 2012-09-30 | $1.05B | $7.57B | 14.29% |
| 2012-06-30 | $1.07B | $7.44B | 14.75% |
| 2012-03-31 | $1.02B | $7.23B | 14.29% |
| 2011-12-31 | $1.02B | $7.09B | 14.42% |
| 2011-09-30 | $0.95B | $7.15B | 13.40% |
| 2011-06-30 | $0.95B | $7.16B | 13.57% |
| 2011-03-31 | $0.92B | $7.01B | 13.26% |
| 2010-12-31 | $0.92B | $6.91B | 13.30% |
| 2010-09-30 | $1.03B | $6.96B | 15.06% |
| 2010-06-30 | $0.97B | $6.87B | 14.27% |
| 2010-03-31 | $1.03B | $6.84B | 15.52% |
| 2009-12-31 | $1.02B | $6.77B | 15.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $22.039B | $7.394B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.617B | 25.27 |
| Stryker (SYK) | United States | $137.290B | 32.08 |
| Boston Scientific (BSX) | United States | $122.743B | 37.38 |
| Medtronic (MDT) | Ireland | $114.552B | 17.05 |
| EssilorLuxottica (ESLOY) | France | $108.842B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.651B | 35.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.030B | 0.00 |
| ResMed (RMD) | United States | $35.117B | 30.92 |
| Koninklijke Philips (PHG) | Netherlands | $30.774B | 23.39 |
| Terumo (TRUMY) | Japan | $28.517B | 40.27 |
| Baxter (BAX) | United States | $19.851B | 13.46 |
| Insulet (PODD) | United States | $16.269B | 68.45 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.605B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.247B | 30.63 |
| Demant (WILYY) | Denmark | $8.667B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.898B | 33.39 |
| Lantheus Holdings (LNTH) | United States | $7.454B | 17.89 |
| ICU Medical (ICUI) | United States | $4.261B | 40.67 |
| Haemonetics (HAE) | United States | $4.084B | 20.20 |
| TG Therapeutics (TGTX) | United States | $3.689B | 39.07 |
| Neogen (NEOG) | United States | $3.599B | 37.75 |
| Prestige Consumer Healthcare (PBH) | United States | $3.534B | 17.61 |
| GN Store Nord (GNNDY) | Denmark | $3.509B | 21.14 |
| Perrigo (PRGO) | Ireland | $3.499B | 11.06 |
| Envista Holdings (NVST) | United States | $3.398B | 18.13 |
| QuidelOrtho (QDEL) | United States | $3.063B | 19.30 |
| Agios Pharmaceuticals (AGIO) | United States | $2.595B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.226B | 37.36 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.124B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.061B | 54.92 |
| Warby Parker (WRBY) | United States | $1.614B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.497B | 10.81 |
| InMode (INMD) | Israel | $1.464B | 9.32 |
| AtriCure (ATRC) | United States | $1.372B | 0.00 |
| Owens & Minor (OMI) | United States | $1.247B | 9.63 |
| Verano Holdings (VRNOF) | United States | $1.184B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.123B | 0.00 |
| Evolus (EOLS) | United States | $1.006B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.894B | 18.55 |
| National Vision Holdings (EYE) | United States | $0.867B | 27.55 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 116.64 |
| Quanterix (QTRX) | United States | $0.489B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.488B | 14.72 |
| Jin Medical (ZJYL) | China | $0.439B | 0.00 |
| ZimVie (ZIMV) | United States | $0.435B | 40.41 |
| Valneva SE (VALN) | France | $0.432B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.389B | 0.00 |
| Cerus (CERS) | United States | $0.324B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.324B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.320B | 8.25 |
| Aurora Cannabis (ACB) | Canada | $0.319B | 0.00 |
| Biote (BTMD) | United States | $0.307B | 14.18 |
| Viemed Healthcare (VMD) | United States | $0.283B | 30.38 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Zynex (ZYXI) | United States | $0.257B | 45.00 |
| Utah Medical Products (UTMD) | United States | $0.232B | 15.41 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.194B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.163B | 67.33 |
| FitLife Brands (FTLF) | United States | $0.153B | 20.64 |
| Brainsway (BWAY) | Israel | $0.135B | 161.40 |
| TriSalus Life Sciences (TLSI) | United States | $0.130B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.121B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.114B | 0.00 |
| Veru (VERU) | United States | $0.113B | 0.00 |
| Fonar (FONR) | United States | $0.111B | 11.44 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.80 |
| InterCure (INCR) | Israel | $0.087B | 14.62 |
| Zevia PBC (ZVIA) | United States | $0.083B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.082B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.071B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Exagen (XGN) | United States | $0.055B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.051B | 3.35 |
| Apyx Medical (APYX) | United States | $0.042B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 21.30 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |